The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Kristoffer Ström

Research engineer

Default user image.

A novel hormone-sensitive lipase isoform expressed in pancreatic beta -cells.


  • Håkan Lindvall
  • Pernilla Nevsten
  • Kristoffer Ström
  • Reine Wallenberg
  • Frank Sundler
  • Dominique Langin
  • Maria Sörhede Winzell
  • Cecilia Holm

Summary, in English

Hormone-sensitive lipase (HSL) is a key enzyme in fatty acid mobilization in many cell types. Two isoforms of HSL are known to date, namely HSLadi (84 kDa in rat) and HSLtes (130 kDa in rat). These are encoded by the same gene, with exons 1-9 encoding the parts that are common to both and an additional 5'-exon encoding the additional amino acids in HSLtes. HSL of various tissues, among these the islet of Langerhans, is larger than HSLadi, but not as large as HSLtes, indicating that there may be other 5'-coding exons. Here we describe the molecular basis for a novel 89-kDa HSL isoform that is expressed in -cells, adipocytes, adrenal glands, and ovaries in the rat and that is encoded by exons 1-9 and exon A, which is spliced to exon 1 and thereby introducing an upstream start codon. The additional 5'-base pairs encode a 43-amino acid peptide, which is highly positively charged. Conglomerates of HSL molecules are in close association with the secretory granules of the -cell, as determined by immunoelectron microscopy with antibodies targeting two separate regions of HSL. We have also determined that the human genomic sequence upstream of exon A has promoter activity in INS-1 cells as well as glucose sensing capability, mediating an increase in expression at high glucose concentration. The minimal promoter is present within 170 bp from the transcriptional start site and maximal glucose responsiveness is conferred by sequence within 850 bp from the transcriptional start site.


  • Department of Experimental Medical Science
  • Centre for Analysis and Synthesis
  • Molecular Endocrinology
  • Medicine, Lund

Publishing year







Journal of Biological Chemistry





Document type

Journal article




  • Cell and Molecular Biology



Research group

  • Molecular Endocrinology


  • ISSN: 1083-351X